1933 Industries (CSE:TGIF,OTCQX:TGIFF) CEO Chris Rebentisch joined the Investing News Network to discuss his company’s fiscal Q2 2020 results, its recent pivot in operations and how COVID-19 is expected to influence the cannabis market moving forward. 

Like many cannabis companies in the North American space, 1933 Industries experienced a pullback during the second fiscal quarter of the year. “The quarter wasn’t as rosy as everybody had anticipated. The company has pivoted its business model over the last six months. We are now heavily focused on consumer branded goods and the revenue that’s generated through that,” said Rebentisch. “The way that you get revenue in this industry is either through retail partners or by owning a retail location. Our business model is to generate revenue through our brand presence, brand equity and consumer loyalty, all of which will drive consumer demand for our brands.”

1933 Industries focused on securing initial revenue before pivoting to scale its successes. “We realized that as experienced operators, we can still build revenue without having to invest in big infrastructure projects. Our approach was to go get revenue, go get sales and then build the infrastructure to support the sales and increase the margins on it, and so the company went out and built a 67,000 square foot cultivation building a year and a half ago that is now running and is fully functional,” said Rebentisch.

The company’s focus on revenue generation has become especially critical following the downturn in sales in the United States, which Rebentisch feels was partially driven by the vaporizer crisis in late 2019. “Sales erosion happened throughout the fall with the vape crisis, and we were heavily dominated by vape sales and distillate sales, so that impacted us,” he said. “The vape crisis contributed to our sales erosion on the marijuana side and then we had some sales erosion on the CBD side too.” In addition to the issues with vape cartridges in the United States, Rebentisch feels the lack of regulation in the American CBD market has hindered the growth of legitimate companies in the sector. “The complete oversaturation of CBD products with new companies coming online every hour has been challenging. With a lack of regulations, anybody can get into the CBD industry and claim whatever they want as they put products out. This really hurts the CBD industry so we’re championing and lobbying behind those who are trying to get regulations in place as soon as possible,” he said.

Moving forward, Rebentisch has recognized the importance of staying nimble in the CBD sector as a means of maintaining revenue and supporting the company’s existing infrastructure. “We’ve had to make some shifts on the CBD side from selling to brick and mortar retail locations to more of a direct to consumer e-commerce approach.”

In line with its strategic adjustments, 1933 Industries has also cut its operational expenses in order to extend its runway. Moving forward, Rebentisch feels that the company is headed in the right direction after a difficult start to the fiscal year 2020. “We identified a lot of things in the company that had to be fixed. We made all those corrections and we funded our infrastructure. Unfortunately, a lot of those expenses and the sales erosion fell out in Q2 as a result of that. But moving forward, the company is now on a strong path to fly once we return to normal conditions.”

On March 13th Nevada announced its ban and stay at home order to deal with the COVID-19 crisis. They named marijuana dispensary, cultivation and production facilities as essential businesses. There was a line wrapped around the building for about three or four days until the governor came out and said no one would be allowed in dispensaries neither would curbside pickup be permitted,” said Rebentisch. “Nevada has never been a delivery-dominant industry as far as marijuana goes. There’s no infrastructure to support the demand and there’s no way to serve the customers. Over the last three weeks, the industry has come together and applied to get expedited approvals on drivers, vehicles and systems to deliver.”

Despite the hardships all businesses are facing during the COVID-19 pandemic, Rebentisch is optimistic that his company has made the right moves to successfully move forward. “We’re putting a lot of resources into brand equity and consumer demand for our products. We have shifted heavily on the CBD side into e-commerce with direct to consumer delivery. So that’s really a major focus for us as people are shifting more towards buying everything online rather than going into stores.”

Moving forward, Rebentisch believes the cost-cutting the company went through before the COVID-19 pandemic has positioned the company well to navigate the rocky path that the cannabis industry will face this year. “When I took over as CEO, we identified a lot of spending that we could cut. We had already cut that prior to COVID-19. Since then, we have temporarily paused all of our projects that have CapEx needs. By doing that, we’re conserving and holding on to our cash. We’re working closely together to make sure that everything we’re spending money on goes to sales. Unfortunately, we’ve had to make cuts on certain things to do that. But the mantra of the company is ‘survive then thrive’ so that’s what we’re doing. We want to conserve our cash position the best we can and weather the storm, knowing that we’re positioned perfectly for when the industry can restart.”


This interview is sponsored by 1933 Industries (CSE:TGIF,OTCQX:TGIFF). This interview provides information that was sourced by the Investing News Network (INN) and approved by 1933 Industries in order to help investors learn more about the company. 1933 Industries is a client of INN. The company’s campaign fees pay for INN to create and update this interview.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with 1933 Industries and seek advice from a qualified investment advisor.

This interview may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, receipt of property titles, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. The issuer relies upon litigation protection for forward-looking statements. Investing in companies comes with uncertainties as market values can fluctuate.

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less